Early Complete Molecular Response to First-Line Nilotinib in Two Patients with Chronic Myeloid Leukemia Carrying the p230 Transcript

Chronic myeloid leukemia (CML) with the rare fusion gene e19a2, encoding a p230 protein, has been described in patients with typical or rather aggressive clinical course. Although tyrosine kinase inhibitors (TKIs) induce a substantial cytogenetic and molecular response in all phases of CML, a minori...

Descripción completa

Detalles Bibliográficos
Autores principales: Greco, Marianna, Caocci, Giovanni, La Nasa, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728508/
https://www.ncbi.nlm.nih.gov/pubmed/23956893
http://dx.doi.org/10.1155/2013/871476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728508/
https://www.ncbi.nlm.nih.gov/pubmed/23956893
http://dx.doi.org/10.1155/2013/871476

Ejemplares similares